Annovis Bio

+$0.87 (+2.81%) As of 1:50 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Annovis Bio and other ETFs, options, and stocks.

About ANVS

Annovis Bio, Inc. is a clinical stage drug platform company, which develops drugs to treat neurodegeneration. The firm compound is ANVS401, which is in Phase 2a clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, Alzheimer's disease in Down Syndrome, and other chronic neurodegenerative disorders.

CEO
Maria-Luisa Maccecchini
Employees
2
Headquarters
Berwyn, Pennsylvania
Founded
2008

ANVS Key Statistics

Market Cap
257.76M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
206.56K
High Today
$31.90
Low Today
$30.95
Open Price
$31.78
Volume
28.97K
52 Week High
$132.00
52 Week Low
$4.14

ANVS Earnings

-$0.46
-$0.31
-$0.15
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 3, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure